JAMA Ophthalmology
JAMA Ophthalmology[edit | edit source]
JAMA Ophthalmology is a peer-reviewed medical journal that focuses on the field of ophthalmology. It is one of the JAMA Network journals, which are published by the American Medical Association. The journal provides a platform for the dissemination of significant clinical and basic research findings in the field of ophthalmology.
History[edit | edit source]
JAMA Ophthalmology was originally established in 1869 as the Archives of Ophthalmology. Over the years, it has undergone several name changes and has been known as JAMA Ophthalmology since 2013. The journal has a long history of publishing influential research that has contributed to advancements in the understanding and treatment of eye diseases.
Scope and Content[edit | edit source]
The journal covers a wide range of topics within ophthalmology, including but not limited to:
- Retina and vitreous
- Cornea and external disease
- Glaucoma
- Neuro-ophthalmology
- Pediatric ophthalmology and strabismus
- Oculoplastics and orbital disease
JAMA Ophthalmology publishes original research articles, reviews, clinical trials, and case reports. It also includes editorials, commentaries, and letters to the editor that provide insights and discussions on current issues in ophthalmology.
Editorial Process[edit | edit source]
The journal employs a rigorous peer-review process to ensure the quality and validity of the research it publishes. Manuscripts submitted to JAMA Ophthalmology are reviewed by experts in the field, and decisions are made based on the novelty, significance, and scientific rigor of the work.
Impact and Influence[edit | edit source]
JAMA Ophthalmology is widely regarded as a leading journal in the field of ophthalmology. It has a high impact factor, reflecting its influence and the importance of the research it publishes. The journal is read by ophthalmologists, researchers, and healthcare professionals worldwide, contributing to the advancement of eye care and treatment.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
